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evaluated using two approaches: 1) target gene expression was meas-
ured using the TOPﬂash TCF/lef luciferase reporter assay, and 2) intra-
cellular signaling partners b-catenin and phospho b-catenin levels were
evaluated by Western blot analysis. Mineralization in response to RSV
was evaluated by Alizarin red staining.
Results: OA Ob showed an increased alkaline phosphatase activity and
osteocalcin release that were partly corrected in presence of increasing
doses of RSV. RSV had little effect on cell proliferation and only slightly
affected the Bax/Bcl2 ratio, an indicator of cell survival. The expression
of Runx2/Cbfa1 and PPARgwere not affected by increasing doses of RSV.
However, although it did not affect Sirtuin1 expression, RSV reduced
the expression of leptin. Moreover, Wnt3a alone increased b-catenin
levels and cWnt signaling activity, and both parameters were further
increased by RSV treatment. The BMP-2-dependent mineralization of
OA Ob, which is also reduced compared to normal, was partially
restored by RSV treatment as detected by alizarin red staining.
Conclusions: These data indicate that RSV can promote the Wnt/b-
catenin signaling pathway which is altered OA Ob. This last situation
could explain the role of RSV on alkaline phosphatase activity, osteo-
calcin release, and in vitro mineralization which are all altered in these
cells.
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ALTERATIONS OF THE NON-CANONICAL WNT/PKC PATHWAY IN
HUMAN OSTEOARTHRITIS OSTEOBLASTS
E. Abed, V. Siwing, X. Martineau, A. Delalandre, D. Lajeunesse. CRCHUM,
Montreal, QC, Canada
Purpose: Clinical and in vitro studies suggest that subchondral bone
sclerosis due to abnormal osteoblasts (Ob) is involved in the pro-
gression and/or onset of osteoarthritis (OA). Human Ob isolated from
sclerotic subchondral OA bone tissue show an altered phenotype, a
decreased canonical Wnt/ß-catenin signaling pathway (cWnt), and a
reduced mineralization in vitro, alterations linked with an abnormal
response to BMP-2. Besides the cWnt pathway, at least two non-can-
onical signaling pathways, the Wnt/PKC and Wnt/PCP pathway have
been described. However, there are no reports of either pathway in OA
Ob. TheWnt/PKC pathway is activated after a non-canonical Wnt ligand
such asWnt5a triggers a leucine-rich G-coupled protein receptor (LGR),
typically LGR4 or LGR5 in osteoblasts. This then drives the phosphor-
ylation of PKC (phosphoPKC), and downstream signaling targets. Here,
we studied if alterations of the Wnt/PKC pathway could be observed in
OA Ob.
Methods: We prepared primary human subchondral Ob using the
sclerotic medial portion of the tibial plateaus of OA patients undergoing
total knee arthroplasty, or from tibial plateaus of normal individuals at
autopsy. The expression of genes involved inWnt/PKC was evaluated by
qRT-PCR and the protein production by Western blot analysis. Alkaline
phosphatase activity (ALPase) and osteocalcin release (OC) were
measured by substrate hydrolysis and EIA respectively. The Wnt/PKC
and JNK pathways were evaluated using Western blot analysis of PKC,
phosphoPKC, JNK and phosphoJNK.
Results: OA Ob showed an increased alkaline phosphatase activity and
osteocalcin release. The expression of Wnt5a was increased in OA Ob
compared to normal. The expression of LGR4 and LGR5 was detected in
both normal and OA Ob, however, although the expression of LGR4 was
only slightly increased in OA Ob, the expression of LGR5 was sig-
niﬁcantly increased in these cells. Moreover, Wnt5a directly stimulated
the expression of LGR5 both at the mRNA level and protein level.
However, Wnt5a did not stimulate the expression of LGR4. Wnt5a
increased the expression of phosphoPKC without altering PKC levels,
and it also stimulated the phosphorylation of JNK.
Conclusions: These data indicate that Wnt5a, which is increased in OA
Ob, can directly increase the expression of LGR5 which in turn stim-
ulates the Wnt/PKC and JNK pathways. The exact role of the non-can-
onical pathway in OA still remains to be determined.
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ENDOGLIN REGULATES TRANSFORMING GROWTH FACTOR-BETA
SIGNALING AND CHONDROCYTE FUNCTION
Y. Chi y, K. Finnson y, A. Philip y, M. Letarte z, M. Kapoor x. yMcGill Univ.,
Montreal, QC, Canada; zUniv. of Toronto, Toronto, ON, Canada; xUniv. of
Montreal, Montreal, QC, CanadaTransforming growth factor-beta (TGF-b) plays a critical role in main-
taining integrity of articular cartilage by promoting synthesis of
extracellular matrix (ECM) proteins such as type II collagen. Dysregu-
lation of TGF-b action results in abnormal cartilage function which
eventually contributes to chronic degenerative joint disorders such as
osteoarthritis (OA).
Purpose: We have previously shown that chondrocytes express endo-
glin, a TGF-b co-receptor, and that endoglin inhibits TGF-b signaling and
decreases type II collagen production in chondrocytes. In addition, we
have shown that endoglin’s expression is upregulated in OA as com-
pared normal human cartilage. These results indicate that endoglin is a
regulator of TGF-b action and ECM turnover in chondrocytes and sug-
gest that endoglin overexpression may promote OA-like phenotype in
chondrocytes. In the current study, we examined whether endoglin
regulates expressions of genes involved in cartilage homeostasis using a
mouse model.
Methods: We used endoglin heterozygous mice (HET) that lack one
endoglin allele since endoglin null mice are embryonically lethal.
Murine chondrocytes were isolated from cartilages from these HET and
their wild-type littermates. Total RNAwas extracted and converted into
cDNA followed by gene expression analysis using a chondrogenesis
pathway speciﬁc PCRarray. Results: Our PCRarray data demonstrates
that HET chondrocytes show increased levels of TGF-b1 and Bone
Morphogenic Protein (BMP)-4 while HET chondrocytes show decreased
levels of cartilage oligomeric matrix protein (COMP) and Type X colla-
gen (n¼ 5). Other genes such as Cadherin-11 and Sox-9 showa decrease
in HET chondrocytes. Conclusion: Our ﬁndings that HET chondrocytes
show increased levels of TGF-b1 and BMP-4, two important cytokines
for ECM maintenance, support our previous in vitro data that endoglin
negatively regulates TGF-b1 action. The HET chondrocytes display
decreased levels of COMP and type X collagen whose expression levels
are known to be increased in OA cartilage. Altogether, these results
support the notion that presence of endoglin negatively regulates TGF-b
action in cartilage. Determining the mechanism by which endoglin
regulates TGF-b signaling and ECM synthesis in chondrocytes in vivo
may provide a basis for the development of novel therapeutic
approaches to improve cartilage integrity.Chondrocyte Biology
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g-SECRETASE INHIBITOR DAPT PREVENTS OSTEOARTHRITIS
PROGRESSION IN MOUSE EXPERIMENTAL MODEL BY INHIBITION
OF NOTCH SIGNALING
Y. Hosaka y, S. Sugita y, K. Okada y, S. Tanaka y, H. Kawaguchi y,z,
T. Saito y,x. y Sensory and Motor System Med., The Univ. of Tokyo, Tokyo,
Japan; z Spine Ctr., Tokyo Kosei Nenkin Hosp., Tokyo, Japan; xBone and
Cartilage Regenerative Med., Faculty of Med., The Univ. of Tokyo, Tokyo,
Japan
Purpose: Notch is a single-pass transmembrane cell surface receptor
which plays a crucial role in cell fate assignment by regulating differ-
entiation and apoptosis during embryogenesis and postnatal develop-
ment. The Notch signaling pathway is regulated by several molecules:
Notch ligands (Delta-like1, 3, 4, or Jagged1 and -2), Notch receptors
(Notch1-4), a transcriptional effector Rbpj, and target transcription factor
Hes/Hey family members. The signaling is initiated by the Notch ligands
on the cell surface binding to the Notch receptors on the adjacent cells.
Upon binding, the Notch receptor is cleaved by proteinases including a
disintegrin and metalloproteinase (Adam), and subsequently by the g-
secretase complex allowing the Notch intracellular domain (ICD) to be
released into the cytoplasm. Then, the ICD translocates to the nucleus and
binds to Rbpj, forming a transcriptional activator and inducing target
genes such as the Hes/Hey family. Previously, we reported the induction
of markers of hypertrophic chondrocytes likeMmp13 and Vegfa by Notch
ICD overexpression in cultured chondrocytes, and the involvement of the
Rbpj-dependent Notch signaling in the endochondral ossiﬁcation process
during skeletal growth and osteoarthritis (OA) development using Rbpj
conditional knockout mice. Here we investigated therapeutic effects of
DAPT (N-[N-(3,5-diﬂurophenylacetate)-L-alanyl]-(S)-phenylglycine t-
butyl ester), a representative g-secretase inhibitor, using a mouse
experimental model.
Methods: We obtained primary articular chondrocytes from 5-day-old
mouse knee joints, and cultured them with or without DAPT (Calbio-
chem) in a differentiation medium (DMEM containing 10% FBS, 10 mM
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S160b-glycerophosphate, and 10 mg/mL ascorbic acid) for 2 weeks. To assess
their hypertrophic differentiation, we quantitated markers of hyper-
trophic chondrocytes by real-time RT-PCR and performed ALP and
Alizarin red S stainings. For in vivo analyses, we created a surgically
induced OA model by resecting the medial collateral ligament and the
medial meniscus in the knee joints of 8-week-old mice. Intraarticular
administration of DAPT was performed twice a week for 10 weeks after
surgical induction. For each administration, we injected 10 mL of 2.5 mM
DAPT solution, which was prepared by diluting 25 mM DAPT in DMSO
with PBS at 1:10,000. OA severity was quantiﬁed by the OARSI histo-
pathology grade 10 weeks after surgery. Expressions of marker proteins
were determined by immunoﬂuorescence.
Results: In the primary culture of mouse articular chondrocytes with
differentiation medium, DAPT treatment suppressed expression of
Mmp13, Vegfa, and Hes1 and inhibited mineralization in a dose-
dependent manner, while it induced Col2a1 expression. These results
were compatible with those from the Notch ICD overexpression
experiments. Intraarticular administration of DAPT inhibited articular
cartilage degradation of the mouse experimental OA model. OARSI
grading conﬁrmed that DAPT caused signiﬁcant resistance to OA pro-
gression. Immunoﬂuorescence showed reduced expression of Mmp13,
Vegfa and Hes1 in the articular carilage with DAPT administration.
Conclusion: Inhibition of Notch signaling by intraarticular admin-
istration of DAPT prevents OA progression in the mouse experimental
model. Notch-related molecules including the Notch ligands, Adam and
g-secretase may be candidate therapeutic targets for OA prevention.
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WNT16 SUPPORTS THE PHENOTYPE OF THE SUPERFICIAL ZONE
CELLS IN CARTILAGE
B.L. Thomas y, G. Nalesso y, J. Sherwood y, J. Bertrand z, P. Achan x,
C. Pitzalis y, F. Dell’Accio y. yWilliam Harvey Res. Inst., Barts and the
London Sch. of Med. and Dentistry, London, United Kingdom; z Inst. for
Experimental Musculoskeletal Med., Univ. Hosp. Munster, Munster,
Germany; xDept. of Orthopaedics, St. Bartholomew’s and The Royal
London Hosp., London, United Kingdom
Purpose: During embryonic skeletogenesis WNT16 is a speciﬁc marker
of the joint interzone which will give rise to the joint and the perma-
nent articular cartilage. In adult joints WNT16 is no longer expressed,
but it becomes rapidly upregulated in the articular cartilage following
injury and in osteoarthritis (OA).
The superﬁcial zone of the articular cartilage contains chondrogenic
progenitor cells which speciﬁcally express WNT16 and Lubricin and are
essential for the long-term maintenance of cartilage homeostasis.
Lubricin in adulthood is essential for joint lubrication and in its absence,
mice develop spontaneous OA.
This study tests the hypothesis that WNT16 contributes to cartilage
homeostasis following injury by supporting the survival, phenotypic
stability, and function of the superﬁcial zone progenitor cells.
Methods: Superﬁcial zone cells (SZC) were isolated from the knees of
neonatal wnt16-/- and wild-type mice by a sequential digestion with
trypsin and collagenase followed by a selection procedure based onadhesion to ﬁbronectin. Deep zone chondrocytes (DZC) were obtained
by further digestion of the joints with collagenase overnight.
Results: Upon isolation, in wild type mice, SZC were characterized by
the expression of Lubricin and WNT16 as previously reported, whereas
DZC expressed Matrilin-1. Chondrocyte marker Sox9 and extracellular
matrix components such as Aggrecan and Collagen2A1 were more
expressed in the DZC as expected.
Lubricin expression was decreased in wnt16-/- and heterozygous SZC
compared to those from wild type mice. Exogenous WNT16 dose-
dependently increased Lubricin expression in wnt16-/- SFZ cells and pri-
mary bovine chondrocytes. WNT16 treatment also dose-dependently
increased the canonical target gene Axin2 and correlated with the TOP-
FLASH reporter assay. Importantly, DKK1 prevented the WNT16-induced
Lubricin upregulation, thereby demonstrating thatmodulation of the gene
occurs through the canonical pathway. Interestingly,WNT-3Awas amuch
stronger activator of the canonical WNT pathway, but it hardly activated
Lubricin expression, thereby suggesting that other, yet unknown, aspects
of WNT16 signalling are essential for its capacity to upregulate Lubricin.
Sox9 expression was increased in wnt16-/- SZC and lost upon WNT16
stimulation in these cells as well as bovine primary chondrocytes.
wnt16-/- SZC also had a higher content of sulphated proteoglycans
when cultured in micromass, (as measured with alcian blue).
Therefore WNT16 maintains the progenitor phenotype of superﬁcial
zone cells and in its absence, these cells acquire a phenotype more
similar to that of the deep zone chondrocytes.
Conclusion: We have discovered that WNT16 supports Lubricin
expression through activation of the canonical WNT pathway and that
WNT16 supports the maintenance of the speciﬁc phenotype of the
superﬁcial zone cells.
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HEDGEHOG SIGNALING REGULATES CHOLESTEROL HOMEOSTASIS IN
OSTEOARTHRITIS
S.A. Ali y, H.C. Whetstone z, B.A. Alman x. yUniv. of Toronto, TORONTO,
ON, Canada; zHosp. for Sick Children, TORONTO, ON, Canada; xDuke
Univ., DURHAM, NC, USA
Current evidence suggests thatmechanical, genetic, andmetabolic factors
play a role in the pathogenesis of osteoarthritis (OA). Hedgehog (Hh)
signaling is known to regulate chondrocyte differentiation, and to be
activated in human and murine OA. Since Hh signaling regulates Gli-
mediated gene expression, we identiﬁed Hh target genes that are
expressed in chondrocytes.Microarrayanalyseswere performed to detect
changes in gene expression when the Hh pathway was modulated in
humanOAcartilage samples. Results from theAffymetrixHumanGene1.0
ST microarray were analyzed for differentially expressed genes from ﬁve
patient samples.Using IngenuityPathwayanalysis, several genesknown
tobe involved in sterolhomeostasiswere found tobeupregulatedwithHh
inhibition. To investigate the function of these genes in cartilage, mice
with chondrocyte-speciﬁc cholesterol accumulationwere generated. This
was achieved by excising Insig1 and Insig2, major negative regulators of
cholesterol homeostasis, under Col2a1 regulatoryelements.With agingor
surgically induced joint instability, mice with chondrocyte-speciﬁc cho-
lesterol accumulation developedmore severe OA than control littermates.
They expressed markers of chondrocyte hypertrophy in the articular
cartilage, including typeX collagen. Statin treatment to inhibit cholesterol
production rescued this phenotype and reduced the severity of OA.
Genetic manipulation of Hedgehog signaling in these mice suggests that
Hh signaling is modulating the phenotype by regulating sterol homeo-
stasis. Here we identiﬁed novel Hh target genes in chondrocytes that
regulate intracellular cholesterol levels, and found that cholesterol dys-
regulation in the chondrocytes predisposes to OA. These data suggest that
pharmacologic correction of intra-articular sterol imbalance can be used
as a treatment for osteoarthritis.
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EXPRESSION AND FUNCTION OF CCAAT/ENHANCER-BINDING
PROTEIN FAMILY IN CHONDROCYTES
T. Okuma y, M. Hirata z,y, S. Chang y, K. Okada y, Y. Mori y,
H. Kobayashi y, S. Sugita y, S. Tanaka y, H. Kawaguchi y,x, T. Saito y,k.
y Sensory and Motor System Med., Faculty of Med., Univ. of Tokyo, Tokyo,
Japan; zHosp. for Sick Children, Toronto, ON, Canada; x Spine and Spinal
Cord Ctr., Tokyo Kosei Nenkin Hosp., Tokyo, Japan; kBone and Cartilage
Regenerative Med., Faculty of Med., Univ. of Tokyo, Tokyo, Japan
